Susceptibility to tobacco smoke related to protease inhibitor PIM subtypes in COPD

M. Gambaryan, N. Didkovsky, A. Kalinina, A. Deev (Moscow, Russian Federation)

Source: Annual Congress 2005 - What's new in tobacco and lung disease
Session: What's new in tobacco and lung disease
Session type: Oral Presentation
Number: 3055
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Gambaryan, N. Didkovsky, A. Kalinina, A. Deev (Moscow, Russian Federation). Susceptibility to tobacco smoke related to protease inhibitor PIM subtypes in COPD. Eur Respir J 2005; 26: Suppl. 49, 3055

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Environmental tobacco smoke exposure and the risk of obstructive lung disease exacerbation
Source: Annual Congress 2005 - Environmental tobacco smoke and obstructive lung disease
Year: 2005

Beyond personal smoking: does environmental tobacco smoke cause chronic obstructive pulmonary disease?
Source: Annual Congress 2005 - Environmental tobacco smoke and obstructive lung disease
Year: 2005

Overview of smoking-related disease
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006



Passive and active smoking in childhood for COPD
Source: Annual Congress 2005 - Does COPD begin in childhood? Reviewing the evidence
Year: 2005

Tobacco smoke and respiratory disease
Source: ISSN=1025-448x, ISBN=1-904097-24-3, page=161
Year: 2002

Tobacco use in relation to COPD and asthma
Source: Eur Respir J 2007; 29: 438-445
Year: 2007



COPD in Chinese nonsmokers
Source: Eur Respir J 2009; 33: 509-518
Year: 2009



Environmental tobacco smoke and health in the elderly
Source: Eur Respir J 2002; 19: 172-181
Year: 2002



Introduction on epidemiological evidence for the early onset of COPD
Source: Annual Congress 2005 - Does COPD begin in childhood? Reviewing the evidence
Year: 2005

Wood smoke exposure and risk of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 27: 542-546
Year: 2006



Effect of 1-year smoking cessation on matrix-metalloproteinases and their inhibitors in COPD
Source: Annual Congress 2006 - Cell biology of asthma and COPD
Year: 2006


Evidence for harm reduction in diseased smokers
Source: Annual Congress 2007 - Targeting smokers by reduction: the "snus" connection revisited
Year: 2007


Workplace smoking restriction and respiratory health: the Irish experience
Source: Annual Congress 2005 - Environmental tobacco smoke and obstructive lung disease
Year: 2005

CTLA4 gene polymorphisms are associated with chronic bronchitis
Source: Eur Respir J 2009; 34: 598
Year: 2009



Differences in the polarization of the inflammatory response of patients with chronic obstructive pulmonary disease (COPD) secondary to smoking and to biomass smoke exposure
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013


Impact of cigarette smoke exposure on host–bacterial pathogen interactions
Source: Eur Respir J 2012; 39: 467-477
Year: 2012



Epidemiology of COPD
Source: Eur Respir Rev 2009; 18: 213-221
Year: 2009



Smoking cessation in patients with respiratory diseases
Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results
Year: 2005


COPD patients‘ response to smoking cessation
Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results
Year: 2005